Molecular Docking and Dynamics Simulations Reveal the Antidiabetic Potential of a Novel Fucoxanthin Derivative from Chnoospora minima
Marine Drugs · 09.12.2025 · 23 (12) · 471
DOI: 10.3390/md23120471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 09.12.2025. Verfasst von Sachini Sigera und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genetics & Molecular Biology Unit, Faculty of Applied Sciences, University of Sri Jayewardenepura, Nugegoda 10250, Sri Lanka. Hauptthemen laut MEDLINE: Xanthophylls, Hypoglycemic Agents, Phaeophyceae. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sri Jayewardenepura.
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder requiring safer and more effective therapeutic alternatives. This study investigates a novel fucoxanthin derivative isolated from the marine brown alga Chnoospora minima using a comprehensive in silico approach. Molecular docking revealed that the derivative exhibited higher binding affinities toward α-amylase (–9.4 kcal/mol) and α-glucosidase (–8.0 kcal/mol) compared to the reference drug acarbose (–8.5 and –7.4 kcal/mol, respectively). Pharmacokinetic analysis predicted good intestinal absorption and P-gp inhibition (0.894) and moderate plasma clearance (7.864 mL/min/kg), while toxicity predictions classified it in toxicity class 3, with no respiratory or ocular toxicity. Drug-likeness evaluation showed only one Lipinski and one Veber rule violation, common for natural products. Molecular dynamics simulations conducted for 100 ns using NAMD 3.0 confirmed stable protein–ligand complexes with average RMSD values of ~1.3 Å and ~1.8 Å for α-amylase and α-glucosidase, respectively, and consistent hydrogen bonding profiles. Structural analysis identified a substitution of the allene bond with an unsaturated ketone at the C8′ position as a key contributor to enhanced enzyme interaction. The findings suggest that this fucoxanthin derivative is a promising natural candidate for T2DM therapy and warrants further investigation through lab experiments (in vitro and in vivo).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics & Molecular Biology Unit, Faculty of Applied Sciences, University of Sri Jayewardenepura, Nugegoda 10250, Sri Lanka.
- Department of Zoology, Faculty of Applied Sciences, University of Sri Jayewardenepura, Nugegoda 10250, Sri Lanka.
- Department of Chemistry, Faculty of Applied Sciences, University of Sri Jayewardenepura, Nugegoda 10250, Sri Lanka.
ORCID-Profile: Sachini Sigera, Kavindu D Theekshana, Shamali Abeywardhana, Laksiri Weerasinghe, Tharindu Senapathi, Dinithi C Peiris
Förderung
- University of Sri Jayewardenepura
Zitieren
APA
Sigera, S., Theekshana, K. D., Dinanja, S. G., Eranga, P., Karunathilake, N., Abeywardhana, S., Weerasinghe, L., Senapathi, T., & Peiris, D. C. (2025). Molecular Docking and Dynamics Simulations Reveal the Antidiabetic Potential of a Novel Fucoxanthin Derivative from Chnoospora minima. Marine Drugs, 23(12), 471. https://doi.org/10.3390/md23120471
Vancouver
Sigera S, Theekshana KD, Dinanja SG, Eranga P, Karunathilake N, Abeywardhana S, et al. Molecular Docking and Dynamics Simulations Reveal the Antidiabetic Potential of a Novel Fucoxanthin Derivative from Chnoospora minima. Marine Drugs. 2025;23(12):471. doi:10.3390/md23120471
BibTeX
@article{Sigera2025,
author = {Sigera, Sachini and Theekshana, Kavindu D and Dinanja, Sathmi G and Eranga, Pasindu and Karunathilake, Nayanatharie and Abeywardhana, Shamali and Weerasinghe, Laksiri and Senapathi, Tharindu and Peiris, Dinithi C},
title = {Molecular Docking and Dynamics Simulations Reveal the Antidiabetic Potential of a Novel Fucoxanthin Derivative from Chnoospora minima},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {12},
pages = {471},
doi = {10.3390/md23120471}
}
EUVIMED